Temazepam (temazepam)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Temazepam is a benzodiazepine.

Temazepam shares the actions of other benzodiazepines and is used as a hypnotic agent in the short-term treatment of insomnia generally for periods not exceeding 7-10 days in duration. The failure of insomnia to remit after 7-10 days of temazepam therapy may indicate the presence of an underlying psychiatric and/or medical condition. Prolonged use of hypnotics is usually not indicated and should be undertaken only upon further evaluation of the patient.

The possibility that insomnia may be a symptom of an underlying condition for which there may be a more specific treatment should be considered.

Generic name: temazepam
Pronunciation: (teh-MAZ-eh-pam)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Temazepam

Intelligence content is not available yet.

Indications

The following indications are listed for Temazepam:

  • Insomnia

Also known as: Agrypnia, Ahypnia.

Dosing

Dosage of temazepam must be individualized, and the smallest effective dosage should be used (especially in geriatric or debilitated patients or in those with liver disease or low serum albumin). Prolonged administration of temazepam should be avoided.

The usual adult dose of temazepam is 15 mg; however, 7.5 mg may be adequate in some patients, while others may require 22.5 or 30 mg. For transient insomnia, 7.5 mg may be adequate to improve sleep latency. In geriatric or debilitated patients, an initial dose of 7.5 mg should be used until individual response is determined. In patients who have received prolonged (e.g., for several months) temazepam therapy at dosages exceeding 15 mg daily, abrupt discontinuance of the drug should be avoided since manifestations of withdrawal can be precipitated; if the drug is to be discontinued in such patients, it is recommended that dosage be gradually tapered.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data